Response to “A Case of 5‐FU‐Related Severe Toxicity Associated With the P.Y186C DPYD Variant”

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|95|2|137-137

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.95, Iss.2, 2014-02, pp. : 137-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of 5‐FU‐Related Severe Toxicity Associated with the p.Y186C DPYD Variant

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 136-136

John Wiley & Sons Inc

Access to resources Recommend Favorite

A DPYD Variant (Y186C) in Individuals of African Ancestry Is Associated With Reduced DPD Enzyme Activity

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 158-166

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 429-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical validity of a DPYD‐based pharmacogenetic test to predict severe toxicity to fluoropyrimidines

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2971-2980

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon lambda 4 variant rs12979860 is not associated with RAV NS5A Y93H in hepatitis C virus genotype 3a

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1377-1378

John Wiley & Sons Inc

Access to resources Recommend Favorite